RecruitingNCT06908980

CHOLE-POSSUM PRO Validation for Prediction of Mortality After Cholecystectomy for Acute Calculous Cholecystitis: Protocol for a Prospective Multicenter Observational Study


Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia

Enrollment

2,500 participants

Start Date

Mar 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

CHOLE-POSSUM PRO is a prospective multicenter observational study on patients with ACC candidate to EC. The rationale of the study is to validate the CHOLE-POSSUM PRO SCORE for 30-day mortality in this population.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

CHOLE-POSSUM PRO is a multicenter observational study for adults 18 and older who have been diagnosed with acute calculous cholecystitis (gallbladder inflammation caused by gallstones) and are undergoing emergency cholecystectomy (gallbladder removal surgery). The study is not testing a new treatment — instead, it aims to validate a scoring tool called the CHOLE-POSSUM PRO score that predicts the risk of death within 30 days after surgery. Eligible patients must meet established diagnostic criteria for acute calculous cholecystitis, be candidates for emergency surgery during their hospital admission, and provide signed informed consent. Participation involves standard clinical care plus the collection of health data needed to test the scoring tool's accuracy. This summary was prepared as patient-facing educational content using AI assistance.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Fondazione IRCCS Policlinico San Matteo

Pavia, Pavia, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06908980